Industry News

Altair Nanotechnologies Appoints Vice President of Manufacturing

Published on 2005-03-30. Author : SpecialChem

RENO, NV -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News), a developer and manufacturer of innovative nanomaterial products, announced that it has appointed Dennis Nagle to the position of Vice President.

"We are pleased to have Dennis join our Management Team," said Altair Nanotechnologies CEO Dr. Alan J. Gotcher. "As Altair moves its nano product technology out of the laboratory and into commercialization it is crucial to have an executive of Dennis' caliber on the team. He has an extensive background in building chemical manufacturing operations that cover all aspects of Altair's business including industrial chemicals, pharmaceuticals and nano materials. His ability to span the needs of small batch production through high volume, continuous manufacturing will be an important factor for Altair in 2005 and beyond."

In this role, Nagle is tasked to lead Altair's manufacturing operations, which produce a range of advanced ceramic nanomaterials from kilogram to ton quantities.

"This is a great time to join the Altair team," commented Nagle. "Altair is uniquely positioned to capitalize on the growth of the nanomaterials industry as Altair's product technology moves into commercial products. Altair's scientists have engineered their products to ensure cost-effective manufacturing. I look forward to working with this team as we build the manufacturing infrastructure that will reliably and reproducibly deliver nanomaterial products."

About Dennis Nagle

Dennis Nagle brings to Altair more than 25 years of chemical industry experience in senior management roles with startup and publicly traded companies. His industry experience includes surface treatment technology, pharmaceuticals intermediates, specialty chemicals, nanocrystalline materials, electronic chemicals and industrial chemicals manufacturing.

Previously Nagle was at Atotech USA, Inc., a supplier to the printed circuit board manufacturing industry, where he held the position of Operations Manager. Prior to Atotech, Nagle held several senior roles including Director of Operations for Zeeland Chemicals, where he implemented process improvements saving the company over $600M in working capital. Before that he was Vice President of Manufacturing for Nanophase Technologies, a nanocrystalline manufacturing company. He has also held senior manufacturing positions with Ashland Chemical Company and Olin Corporation. Nagle received Bachelor of Science degrees in Chemical Engineering and Engineering Administration from Michigan Technological University.


Altair Nanotechnologies, through product innovation, is a leading supplier of advanced ceramic nanomaterial technology worldwide. Altair Nanotechnologies has assembled a unique team of material scientists who, coupled with collaborative ventures with industry partners and leading academic centers, has pioneered an impressive array of intellectual property and product achievements.

Altair Nanotechnologies has developed robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nanomaterials of unique structure, performance, quality and cost. The company has a scalable manufacturing capability to meet emerging nanomaterials demands, with capacity today to produce hundreds of tons of nanomaterials.

The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for paints and coatings; titanium metal manufacturing, catalysts and water treatment; and alternative energy.

Altair Nanotechnologies, Inc.®, Altair Nanomaterials(TM), Altairnano(TM), TiNano®, RenaZorb(TM), NanoCheck(TM), TiNano Spheres(TM) and the Hydrochloride Pigment Process(TM) are trademarks or registered trademarks of Altair Nanotechnologies, Inc.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company's actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that Altair expenses will rise during the following quarters as a result of unexpected cash or non-cash expenses; Altair's numerous development stage products will not be developed to the point of commercialization or that, even if commercialized, no market will exist for such products or Altair will fail to effectively market to customers in a market, the risks that Altair will be unable to enter into license agreements regarding its pigment process (AHPP), RenaZorb, its TiNano Sphere or other developing products, that even if Altair enters into such license agreements, short term revenues from such agreements will not be sufficient to fund Altair's operations in the long run, and that animal testing or future testing of RenaZorb or other products of the company will not be successful and that development will need to be terminated. In general, Altair is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. In addition, other risks are identified in the company's most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.

Source: Altair Nanotechnologies, Inc.

Omya Calcium Carboantes
Back to Top